Identification of the von Hippel���Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

Mutations of von Hippel���Lindau disease (VHL) tumor-suppressor gene product (pVHL) are found in patients with dominant inherited VHL syndrome and in the vast majority of sporadic clear cell renal carcinomas. The function of the pVHL protein has not been clarified. pVHL has been shown to form a complex with elongin B and elongin C (VBC) and with cullin (CUL)-2. In light of the structural analogy of VBC-CUL-2 to SKP1-CUL-1-F-box ubiquitin ligases, the ubiquitin ligase activity of VBC-CUL-2 was examined in this study. We show that VBC-CUL-2 exhibits ubiquitin ligase activity, and we identified UbcH5a, b, and c, but not CDC34, as the ubiquitin-conjugating enzymes of the VBC-CUL-2 ubiquitin ligase. The protein Rbx1/ROC1 enhances ligase activity of VBC-CUL-2 as it does in the SKP1-CUL-1-F-box protein ligase complex. We also found that pVHL associates with two proteins, p100 and p220, which migrate at a similar molecular weight as two major bands in the ubiquitination assay. Furthermore, naturally occurring pVHL missense mutations, including mutants capable of forming a complex with elongin B���elongin C-CUL-2, fail to associate with p100 and p220 and cannot exhibit the E3 ligase activity. These results suggest that pVHL might be the substrate recognition subunit of the VBC-CUL-2 E3 ligase. This is also, to our knowledge, the first example of a human tumor-suppressor protein being directly involved in the ubiquitin conjugation system which leads to the targeted degradation of substrate proteins.

Expression of adenoviral E3 transgenes in �� cells prevents autoimmune���diabetes

The adenovirus (Ad) genome contains immunoregulatory and cytokine inhibitory genes that are presumed to function in facilitating acute infection or in establishing persistence in vivo. Some of these genes are clustered in early region 3 (E3), which contains a 19-kDa glycoprotein (gp19) that inhibits the transport of selected class I major histocompatibility complex (MHC) molecules out of the endoplasmic reticulum. In addition, the E3 region contains three protein inhibitors of the cytolytic function of tumor necrosis factor �� (TNF-��). Because type I autoimmune diabetes destroys islets by mechanisms that involve class I MHC and TNF-��, we investigated whether the entire cassette of Ad E3 genes might prevent the onset of diabetes in a well studied lymphocytic choriomeningitis viral (LCMV) murine model of virus-induced autoimmune diabetes. In this model, a LCMV polypeptide (either glycoprotein or nucleoprotein) expressed as a transgene in the islets is a target for autoimmune destruction of �� cells after LCMV infection. In this scenario the LCMV-induced immune response is directed not only against the virus but also against the LCMV transgenes expressed in the �� cells. Our experiments demonstrated a very efficient prevention of this LCMV-triggered diabetes by the Ad E3 genes. This resulted from the inhibition of target cell recognition by a fully competent and LCMV-primed immune system. Unlike the results from the ��-2 microglobulin gene deletion experiments, our approach shows that selective regulation at the level of the target cell is sufficient to prevent autoimmune diabetes without disrupting the function of the systemic immune response. Although the Ad genes in these experiments were provided as transgenes, recent experiments may permit the introduction of such genes through the use of viral vectors. Although the decrease in class I MHC in islets by Ad genes was demonstrated in these in vivo studies, the relative importance of this process and the control of TNF-�� cytolysis must await further genetic dissection of the introduced Ad genes.

Specificity in transforming growth factor ��-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor ��E3, and Smad proteins

Transforming growth factor �� (TGF-��) regulates a broad range of biological processes, including cell growth, development, differentiation, and immunity. TGF-�� signals through its cell surface receptor serine kinases that phosphorylate Smad2 or Smad3 proteins. Because Smad3 and its partner Smad4 bind to only 4-bp Smad binding elements (SBEs) in DNA, a central question is how specificity of TGF-��-induced transcription is achieved. We show that Smad3 selectively binds to two of the three SBEs in PE2.1, a TGF-��-inducible fragment of the plasminogen activator inhibitor-1 promoter, to mediate TGF-��-induced transcription; moreover, a precise 3-bp spacer between one SBE and the E-box, a binding site for transcription factor ��E3 (TFE3), is essential for TGF-��-induced transcription. Whereas an isolated Smad3 MH1 domain binds to TFE3, TGF-�� receptor-mediated phosphorylation of full-length Smad3 enhances its binding to TFE3. Together, these studies elucidate an important mechanism for specificity in TGF-��-induced transcription of the plasminogen activator inhibitor-1 gene.

Division of Labor among the ��6��4 Integrin, ��1 Integrins, and an E3 Laminin Receptor to Signal Morphogenesis and ��-Casein Expression in Mammary Epithelial Cells

Contact of cultured mammary epithelial cells with the basement membrane protein laminin induces multiple responses, including cell shape changes, growth arrest, and, in the presence of prolactin, transcription of the milk protein ��-casein. We sought to identify the specific laminin receptor(s) mediating the multiple cell responses to laminin. Using assays with clonal mammary epithelial cells, we reveal distinct functions for the ��6��4 integrin, ��1 integrins, and an E3 laminin receptor. Signals from laminin for ��-casein expression were inhibited in the presence of function-blocking antibodies against both the ��6 and ��1 integrin subunits and by the laminin E3 fragment. The ��6-blocking antibody perturbed signals mediated by the ��6��4 integrin, and the ��1-blocking antibody perturbed signals mediated by another integrin, the �� subunit(s) of which remains to be determined. Neither ��6- nor ��1-blocking antibodies perturbed the cell shape changes resulting from cell exposure to laminin. However, the E3 laminin fragment and heparin both inhibited cell shape changes induced by laminin, thereby implicating an E3 laminin receptor in this function. These results elucidate the multiplicity of cell-extracellular matrix interactions required to integrate cell structure and signaling and ultimately permit normal cell function.

The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity

The infected cell protein 0 (ICP0) of herpes simplex virus 1, a promiscuous transactivator shown to enhance the expression of genes introduced into cells by infection or transfection, interacts with numerous cellular proteins and has been linked to the disruption of ND10 and degradation of several proteins. ICP0 contains a RING finger domain characteristic of a class of E3 ubiquitin ligases. We report that: (i) in infected cells, ICP0 interacts dynamically with proteasomes and is bound to proteasomes in the presence of the proteasome inhibitor MG132. Also in infected cells, cdc34, a polyubiquitinated E2 ubiquitin-conjugating enzyme, exhibits increased ICP0-dependent dynamic interaction with proteasomes. (ii) In an in vitro substrate-independent ubiquitination system, the RING finger domain encoded by exon 2 of ICP0 binds cdc34, whereas the carboxyl-terminal domain of ICP0 functions as an E3 ligase independent of the RING finger domain. The results indicate that ICP0 can act as a unimolecular E3 ubiquitin ligase and that it promotes ubiquitin-protein ligation and binds the E2 cdc34. It differs from other unimolecular E3 ligases in that the domain containing the RING finger binds E2, whereas the ligase activity maps to a different domain of the protein. The results also suggest that ICP0 shuttles between nucleus and cytoplasm as a function of its dynamic interactions with proteasomes.

���Estudio de los mecanismos moleculares involucrados en la inmunosupresi��n observada durante la infecci��n con Trypanosoma cruzi: Rol de la v��a PD-1/PD1-L y E3 ubiquitina ligasas���.

Trypanosoma cruzi es el agente causal de la enfermedad de Chagas, un problema de salud importante en Am��rica Latina, as�� como tambi��n en Am��rica Central, ya que causa infecci��n cr��nica afectando a millones de personas [1]. Durante esta enfermedad se han descripto varias alteraciones de la respuesta inmune, entre ellas una severa inmunosupresi��n durante la etapa aguda de la infecci��n, tanto en humanos como en ratones. C��lulas T provenientes de ratones infectados activadas in vitro, muestran reducci��n en la respuesta proliferativa a mit��genos, caracter��stica de un estado de inmunosupresi��n [2-4]. La falla del sistema inmune durante estadios tempranos de la infecci��n probablemente colabore con la diseminaci��n y el establecimiento del par��sito. Un gran n��mero de estudios se han focalizado en la identificaci��n de mecanismos moleculares responsables del fen��meno de inmunosupresi��n, entre los mecanismos citados se ha demostrado presencia de c��lulas supresoras [5-9], factores inmunosupresores presentes en el par��sito [2, 3, 10-13], producci��n excesiva de ��xido n��trico [14], disminuida producci��n de IL-2 y reducida expresi��n del receptor de IL2 en c��lulas de bazo de animales infectados [9, 15-17]. Muchos de estos mecanismos han sido exhaustivamente investigados, sin embargo no est�� del todo claro si existen mecanismos adicionales involucrados en la inmunosupresi��n de la c��lula T. Adicionalmente, en los ��ltimos a��os nuevas mol��culas que median la regulaci��n negativa de la c��lula T, entre las cuales est��n PD-1/PD1-L [18], arginasa [19] y E3 ubiquitina ligasas [20-22], han sido reportadas durante inmunosupresi��n en diversas infecciones.

E3+3 coercive diplomacy towards Iran: Do the economic sanctions add up? CEPS Policy Brief No. 292, 6 June 2013

More than ten years of international negotiations have brought no resolution to the nuclear dispute with Iran. In January 2012 the EU and US autonomously adopted an unprecedented sanctions package, mainly directed at the Iranian oil industry. Eighteen months later, figures show that the Iranian economy has been hit hard. Sanctions have not changed the regime���s calculus, however. Instead of further upping the pressure on Iran, the authors argue for a return to a more balanced dual-track approach so as to reinforce the moderate narrative within the Iranian ruling elite.

Macroeconomic Scenarios for the Euro-Mediterranean Area Quantification based on the GEM-E3 Model. MEDPRO Report No. 7, July 2013

Four alternative macroeconomic scenarios for southern Mediterranean countries are quantified in this study with the use of GEM-E3, a general equilibrium model. These are i) the continuation of current policies (business-as-usual scenario), ii) southern Mediterranean���EU cooperation (Euro-Mediterranean Union scenario), iii) a global opening of the southern Mediterranean countries and cooperation with the rest of the Middle East and other developing countries like China (Euro-Mediterranean alliance scenario), and iv) a deterioration in the regional political climate and a failure of cooperation (Euro-Mediterranean under threat scenario). Explicit assumptions on trade integration, infrastructure upgrade, population and governance developments are adopted in each scenario. The simulation results indicate that an infrastructure upgrade and governance improvements in the context of southern Mediterranean���EU cooperation could benefit most of the countries under consideration. The analysis remains important in light of ongoing regional developments and the need to design the best policies to pursue in the aftermath of the Arab spring.

NOR network transduction based on error-compensation : principles of NOR network transduction programs NETTRA-E1, NETTRA-E2, and NETTRA-E3 /

Bibliography: p. 101-102.

Program manual : NOR network transduction based on error-compensation : (Reference manual of NOR network transduction programs NETTRA-EL, NETTRA-E2, and NETTRA-E3) /

"Work supported in part by the National Science Foundation under Grant no. GJ-40221."

Impacts of energy taxation in the enlarged European Union, evaluation with GEM-E3 Europe

The objective of this study is twofold: first to analyze how the implementation of the EU energy tax policies will affect the EU and its Member States and secondly to analyze how energy tax policies can contribute to climate policy objectives in the enlarged EU.

On analysing and interpreting variability in motor output

A recent article in the Journal of Science and Medicine in Sport by Chapman et al.1 reported data from an empirical investigation comparing lower extremity joint motions, joint coordination and muscle recruitment in expert and novice cyclists. 3D kinematic and intramuscular electromyographic (EMG) analyses revealed no differences between expert and novice cyclists for normalised joint angles and velocities of the pelvis, hip, knee and ankle. However, significant differences in the strength of sagittal plane kinematics for hip���ankle and knee���ankle joint couplings were reported, with expert cyclists displaying tighter coupling relationships than novice cyclists. Furthermore, significant differences between expert and novice cyclists for all muscle recruitment parameters, except timing of peak EMG amplitude, were also reported.

Clusterin facilitates COMMD1 and I-kB degradation to enhance NF-kB activity in prostate cancer cells

Secretory clusterin (sCLU) is a stress-activated, cytoprotective chaperone that confers broad-spectrum cancer treatment resistance, and its targeted inhibitor (OGX-011) is currently in phase II trials for prostate, lung, and breast cancer. However, the molecular mechanisms by which sCLU inhibits treatment-induced apoptosis in prostate cancer remain incompletely defined. We report that sCLU increases NF-��B nuclear translocation and transcriptional activity by serving as a ubiquitin-binding protein that enhances COMMD1 and I-��B proteasomal degradation by interacting with members of the SCF-��TrCP E3 ligase family. Knockdown of sCLU in prostate cancer cells stabilizes COMMD1 and I-��B, thereby sequestrating NF-��B in the cytoplasm and decreasing NF-��B transcriptional activity. Comparative microarray profiling of sCLU-overexpressing and sCLU-knockdown prostate cancer cells confirmed that the expression of many NF-��B���regulated genes positively correlates with sCLU levels. We propose that elevated levels of sCLU promote prostate cancer cell survival by facilitating degradation of COMMD1 and I-��B, thereby activating the canonical NF-��B pathway.